Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Apollo Hospitals Q1...

    Apollo Hospitals Q1 net profit tumbles 51 percent to Rs 35.21 crore

    Written by Ruby Khatun Khatun Published On 2017-08-16T12:03:23+05:30  |  Updated On 16 Aug 2017 12:03 PM IST
    Apollo Hospitals Q1 net profit tumbles 51 percent to Rs 35.21 crore

    New Delhi: Apollo Hospitals Enterprise on Monday reported 51.21 per cent dip in standalone net profit to Rs 35.21 crore for June 2017 quarter, mainly on account of higher depreciation and interest costs on adding new beds.


    The company had reported a net profit of Rs 72.17 crore in the year-ago period, Apollo Hospitals said in a filing to BSE.


    Total income from operations however rose to Rs 1,684.46 crore for the said quarter as against Rs 1,465.43 crore in April-June 2016, it added.


    The profit after tax was lower mainly due to impact of higher depreciation and interest costs on the over 2,000 new beds created in the last three years, the benefits of which will be visible in higher EBITDA in the next two-three years, Apollo Hospitals said.


    "With over 2,400 new beds added in the last three years, we continue to have a pre-eminent position in the hospital landscape in the country and now have clear plans to further augment our clinical offerings in specialities like Oncology, Neurosciences, Orthopaedics and Transplants," Chairman Prathap C Reddy said.


    The company also informed that its Board took note of resignations of Habibullah Badsha, Raj Kumar Menon and Rafeeque Ahamed as independent directors with effect from today.


    The Board also approved the appointment of BVR Mohan Reddy as an additional director with effect from Monday to hold office as an independent director, it added.

    additional directorApolloApollo HospitalsappointmentBVR Mohan ReddyEBITDAFinancial resultsHabibullah Badshaindependent directorsnet profitNeurosciencesoncologyorthopaedicsPrathap C Reddyprofit after taxRafeeque AhamedRaj Kumar MenonresignationsstandaloneTotal incometumbles
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok